Hypopharynx Cancer, also known as hypopharyngeal cancer, is related to larynx cancer and laryngeal benign neoplasm. An important gene associated with Hypopharynx Cancer is MIR489 (MicroRNA 489), and among its related pathways/superpathways are PI3K-Akt signaling pathway and Signaling by Receptor Tyrosine Kinases. The drugs Atezolizumab and Bevacizumab have been mentioned in the context of this disorder. Affiliated tissues include lymph node and tongue, and related phenotypes are Increased shRNA abundance (Z-score > 2) and Decreased viability